e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Clinical challenges in tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
C-reactive protein in differentiation between tuberculous and malignant pleural effusions
M. Sedky, I. Radwan, M. Mohamed (Cairo, Egypt)
Source:
Annual Congress 2011 - Clinical challenges in tuberculosis
Session:
Clinical challenges in tuberculosis
Session type:
Thematic Poster Session
Number:
2715
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Sedky, I. Radwan, M. Mohamed (Cairo, Egypt). C-reactive protein in differentiation between tuberculous and malignant pleural effusions. Eur Respir J 2011; 38: Suppl. 55, 2715
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion
Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status
Year: 2021
Diagnostic value of procalcitonin and C-reactive protein in the differentiation among bening and malignant pleural effusion
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Role of C-reactive protein in distinguishing between transudative and exudative pleural effusion
Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Year: 2019
The implication of C-reactive protein in differentiation of various pleural effusion etiologies
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008
Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012
The diagnostic value of pleural fluid C-reactive protein level in pleural effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002
The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Biomarkers of infection for the differential diagnosis of pleural effusions
Source: Eur Respir J 2009; 34: 1383-1389
Year: 2009
Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions
Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions
Year: 2010
Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions
Source: Eur Respir J 2003; 22: Suppl. 45, 60s
Year: 2003
Diagnostic value of C-reactive protein in exudative pleural effusions
Source: International Congress 2019 – Clinical problems
Year: 2019
Correlation between pleural fluid and serum C-reactive protein in patients with pleural effusion due to different etiologies
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020
Combined pleural CRP and chest ultrosonography for discrimination between tuberculous and malignant pleural effusion
Source: Eur Respir J 2005; 26: Suppl. 49, 414s
Year: 2005
The value of IL6 in differentiation between malignant and non malignant pleural effusion
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012
Pleural fluid interleukin-10 level in the diagnosis of tuberculous effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 581s
Year: 2002
Rapid evaluation of exudative pleural effusion using C-reactive protein
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept